2
Great Honor for Swiss Therapist in America. Snoring and Sleep Apnea Researcher Alex Suarez receives Ig-Nobel Prize
mehr
Storys aus Boston
-
Sprache:
Englisch
- Medien:
- Zeitraum:
- Zeitraum:Gesamt
Mérieux Développement Announces Equity Financing into Xeris Pharmaceuticals
Lyon, France and Boston (ots/PRNewswire) - Mérieux Développement has recently concluded an equity investment into Xeris Pharmaceuticals, Inc., a specialty biopharmaceutical company focused on the development and commercialization of novel formulations of injectable drugs. With this additional financing, Xeris Pharmaceuticals expects to fund registration trials and ...
mehrBluebee Appoints Two Independent Board Members
Boston and Rijswijk, Netherlands (ots/PRNewswire) - Bluebee Holding BV, a leading provider of high performance genomics solutions, today announced the appointment of two new members to its Board of Directors. Lars Kongsbak has been appointed as an independent director, and Nicolas Roelofs will become Chairman of the Board. About Nicolas H Roelofs An Industrial Advisor with Nordic Capital LTD, he has gained significant ...
mehrSaxenda® demonstrated significant improvements in cardiometabolic risk factors over three years compared with placebo
Boston (ots/PRNewswire) - For non-US medical media only. For journalistic assessment and preparation before publication. Oral Presentation# OR36-1 Today, new data from the three-year part of the phase 3a SCALE(TM) (Satiety and Clinical Adiposity - Liraglutide Evidence) Obesity and Prediabetes trial were presented at ...
mehrVictoza® (liraglutide 1.8 mg) Provided Superior HbA1c Reductions in Adults with Type 2 Diabetes Compared to Continued Sitagliptin Treatment
Boston (ots/PRNewswire) - For non-US medical media only. For journalistic assessment and preparation before publication. Abstract #689-P Findings from a clinical trial comparing Victoza® (liraglutide 1.8 mg) and sitagliptin (100 mg), both in combination with metformin, demonstrated that switching from sitagliptin ...
mehrSemaglutide Demonstrated Superior Improvements In Glycaemic Control Vs Placebo In Adults With Type 2 Diabetes
Boston (ots/PRNewswire) - For non-US medical media only. For journalistic assessment and preparation before publication. Abstract #OR15-1 Findings from the first phase 3a clinical trial for semaglutide, an investigational glucagon-like peptide-1 (GLP-1) analogue, demonstrated that treatment with semaglutide ...
mehr
Gartner Places Positive Technologies as the Most Visionary in Visionaries Quadrant
London And Boston (ots/PRNewswire) - Positive Technologies, a leading provider of security solutions, today announced it has been positioned by Gartner, Inc. in the "Visionaries" quadrant of the Gartner Magic Quadrant for Web Application Firewalls. Positive Technologies is placed the furthest to the right in the Visionaries quadrant based on its completeness of vision. ...
mehrNew Xultophy® (IDegLira) Phase 3b Study Showed Statistically Significant HbA1c Reduction, Body Weight Change and Lower Rate of Hypoglycaemia Versus Insulin Glargine
Boston (ots/PRNewswire) - - 166-OR This material is intended for medical non-UK media only. For journalistic assessment and preparation before publication. New phase 3b findings showed adults with type 2 diabetes treated with Xultophy(R) (IDegLira), a once-daily, single-injection combination of insulin degludec and ...
mehrNew Study With Victoza® (Liraglutide) Showed Improvements in Blood Glucose Control in Adults With Type 2 Diabetes Who Fasted During Ramadan
Boston, Massachusetts (ots/PRNewswire) - This material is intended for medical non-UK media only. For journalistic assessment and preparation before publication Abstract #1121-P New findings showed that adults with type 2 diabetes treated with Victoza(R) , in combination with metformin, experienced similar ...
mehrReturn to Growth for Pharmaceutical Sector: Surge in Drug Approvals, R&D Productivity and Investor Confidence to Drive Expansion Through 2018
London And Boston (ots/PRNewswire) - The industry is poised for a healthier turn after sales declined in 2012, says Evaluate's "World Preview 2013, Outlook to 2018" report According to the newly-released World Preview report from market intelligence firm Evaluate Ltd, the worst of the patent cliff is behind us. ...
mehrPharma in 2012: Boom or Bust?
London And Boston (ots/PRNewswire) - EP Vantage(R) [http://www.epvantage.com/default.aspx ], EvaluatePharma(R) [http://www.evaluatepharma.com ]'s award-winning editorial team, today released its "2012 Year in Review [http://www.evaluatepharma.com/epvreview2012 ]" report. Despite numerous ups and downs, the sector exited on a positive note, giving hope that 2013 might be the start of sustained recovery. According to the report, Biotech stocks stormed ahead with the NASDAQ ...
mehrPhase 2 Results Show INCIVO® (telaprevir), in Combination With Peginterferon Alfa and Ribavirin, is Effective in Treating Patients Co-infected With Genotype-1 Chronic Hepatitis C Virus and HIV
Boston, Massachusetts (ots/PRNewswire) - - Study presented at American Association for the Study of Liver Diseases 2012 shows high sustained virological response (SVR) in HCV/HIV co-infected patients receiving INCIVO(R) (telaprevir)-based regimen - Janssen Infectious Diseases-Diagnostics BVBA (Janssen) today ...
mehr
Medtech Market to Achieve Global Sales of $440 Billion by 2018
London And Boston (ots/PRNewswire) - - EvaluateMedTech(TM) World Preview 2018 Reveals Medtech Sales Growth Rate Forecast to Outperform Global Prescription Drug Market Between 2011 and 2018 EvaluatePharma [http://www.evaluatepharma.com ](R) the premier source for life science sector analysis and consensus forecasts, today released its EvaluateMedTech(TM) World Preview 2018 [http://www.evaluatemedtech.com/MT2018 ] report at ...
mehrEvaluatePharma Launches New Service for the Global Medical Device and Diagnostic Industry
London And Boston (ots/PRNewswire) - EvaluatePharma [http://www.evaluatepharma.com ], the premier source for life science sector analysis and consensus forecasts, today announced the launch of EvaluateMedTech [http://www.evaluatemedtech.com ](TM), a new intelligence service focused on the medical device and diagnostic sector. Powered by EvaluatePharma's proven platform ...
mehrEvaluatePharma Appoints Alexander Karle as COO
London And Boston (ots/PRNewswire) - EvaluatePharma [http://www.evaluategroup.com ](R), the premier source for life science sector analysis and consensus forecasts, has appointed Alexander Karle as Chief Operating Officer. Karle's experience in formulating customer-centric growth strategies and leading them to successful implementation will be instrumental in driving EvaluatePharma's continued expansion within key ...
mehrEvaluatePharma Names Debbie Paul CEO, Americas to Lead Growth in Key Region
Boston (ots/PRNewswire) - EvaluatePharma [http://www.evaluatepharma.com ](R), the premier source for pharmaceutical and biotechnology sector analysis and consensus forecasts, has named Debbie Paul to the position of CEO Americas, EvaluatePharma USA, Inc. effective immediately. In her new role, Paul leads EvaluatePharma's growing North American operations and its ...
mehr
Vorherige123